- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 209/36 - Atomes d'oxygène en position 3, p. ex. adrénochrome
Détention brevets de la classe C07D 209/36
Brevets de cette classe: 65
Historique des publications depuis 10 ans
|
5
|
3
|
7
|
5
|
3
|
2
|
4
|
4
|
2
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Musc Foundation for Research Development | 352 |
5 |
| Biosynth AG | 63 |
4 |
| Azora Therapeutics, Inc. | 13 |
4 |
| Beth Israel Deaconess Medical Center, Inc. | 865 |
3 |
| Syntara Limited | 9 |
3 |
| Amira Pharmaceuticals, Inc. | 69 |
2 |
| National University Corporation Kobe University | 532 |
2 |
| U.S. Department of Veterans Affairs | 55 |
2 |
| New Mexico Tech University Research Park Corporation | 49 |
2 |
| Bristol-myers Squibb Company | 4845 |
1 |
| Boehringer Ingelheim International GmbH | 4641 |
1 |
| Centre National de La Recherche Scientifique | 10611 |
1 |
| FUJIFILM Corporation | 29714 |
1 |
| The General Hospital Corporation | 4784 |
1 |
| Georgia Tech Research Corporation | 2797 |
1 |
| Bionomics Limited | 89 |
1 |
| Board of Trustees of Southern Illinois University | 97 |
1 |
| The Broad Institute, Inc. | 1856 |
1 |
| Cambridge Display Technology Limited | 491 |
1 |
| Clark Atlanta University, Inc. | 10 |
1 |
| Autres propriétaires | 27 |